Enveric Biosciences Sells Cannabinoid-Related IP To Focus On Emerging Psychedelic-Inspired Drugs

GL
Goodmans LLP

Contributor

Goodmans LLP logo
Goodmans is internationally recognized as one of Canada’s pre-eminent business law firms. Based in Toronto, the firm has market-leading expertise in M&A, corporate and transaction finance, private equity, real estate, tax, restructuring, litigation, intellectual property and other business-related specialties.
Enveric Biosciences ("Enveric") has reportedly now sold one of its portfolios comprised of patents and patent applications for cancer treatment that combines cannabidiol ("CBD")...
Worldwide Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.
This Article is waiting for corrections.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More